Polymorphisms in glycogen synthase kinase beta (GSK3B), a regulator of glycogen synthase activity, and skeletal muscle glycogen synthase 1 (GYS1) have been examined in several studies, but have generally failed to associate with diabetes or measures of insulin resistance [36,37]. The gene discussed is GYS1; the disease is Insulin resistance.